Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 0 | 28,312 |
| Cost of Goods | N/A | N/A | N/A | N/A | 433 |
| Gross Profit | N/A | N/A | N/A | N/A | 27,879 |
| Operating Expenses | 37,714 | 44,986 | 35,745 | 23,733 | 67,619 |
| Operating Income | -37,714 | -44,986 | -35,745 | -23,733 | -39,307 |
| Interest Expense | 1,133 | 455 | 1,059 | 3,597 | 0 |
| Other Income | -724 | -6,457 | 1,609 | -878 | -15,266 |
| Pre-tax Income | -39,571 | -51,898 | -35,195 | -28,208 | -54,573 |
| Net Income Continuous | -39,571 | -51,898 | -35,195 | -28,208 | -54,573 |
| Net Income | $-39,571 | $-51,898 | $-35,195 | $-28,208 | $-54,573 |
| EPS Basic Total Ops | -2.58 | -4.25 | -6.96 | -89.27 | -19.30 |
| EPS Basic Continuous Ops | -2.58 | -4.25 | -6.96 | -89.27 | -19.32 |
| EPS Diluted Total Ops | -2.58 | -4.25 | -6.96 | -89.27 | -19.30 |
| EPS Diluted Continuous Ops | -2.58 | -4.25 | -6.96 | -89.27 | -19.32 |
| EPS Diluted Before Non-Recurring Items | -2.58 | -4.25 | -6.96 | -9.80 | -13.10 |
| EBITDA(a) | $-36,369 | $-43,733 | $-34,575 | $-22,676 | $-36,622 |